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The anterior and intermediate lobes of the pituitary gland are formed from Rathke’s pouch. FGF, BMP and WNT signals emanating from the
ventral diencephalon influence pouch growth and development. In order to examine the role of canonical WNT signaling during pituitary
development we examined the pituitary expression of the TCF/LEF family of transcription factors, which mediate WNT signaling through the
binding of β-catenin. We report here the expression of several members of this family during pituitary development and the functional role of one
member, TCF4 (TCF7L2), in the induction of the pituitary primordium. TCF4 is expressed in the ventral diencephalon early in pituitary
development, rostral to a domain of BMP and FGF expression. Tcf4 deficient mice express Fgf10 and Bmp4; however, the Bmp and Fgf
expression domains are expanded rostrally. As a result, additional pituitary progenitor cells are recruited into Rathke’s pouch in Tcf4 mutants.
Mutants also exhibit an expansion of the Six6 expression domain within Rathke’s pouch, which may increase the number of proliferating pouch
cells, resulting in a greatly enlarged anterior pituitary gland. This suggests that TCF4 negatively regulates pituitary growth through two
mechanisms. The first mechanism is to restrict the domains of BMP and FGF signaling in the ventral diencephalon, and the second mechanism is
the restriction of Six6 within Rathke’s pouch. Thus, TCF4 is necessary both intrinsically and extrinsically to Rathke’s pouch to ensure the proper
growth of the pituitary gland.
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Cell signaling through Wnt ligand activated pathways can
regulate developmental processes such as cell proliferation,
differentiation, and migration. Targeted disruption of Wnt genes
leads to a variety of phenotypes including defects in brain, lung,
limb, and kidney development. Pituitary gland development is
also dependent on the proper expression of Wnt ligands. Wnt5a
regulates the shape of the pituitary gland, and Wnt4 enhances
pituitary growth (Treier et al., 1998, Cha et al., 2004). In
addition, cell culture and pituitary explant studies have im-
plicated β-catenin in the regulation of PITX2, NR5A1, and
PROP1, which are all transcription factors critical for pituitary
development. These observations suggest that Wnt ligands
signaling through the β-catenin dependent canonical pathway⁎ Corresponding author. Fax: +1 734 763 3784.
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doi:10.1016/j.ydbio.2007.08.046could be important for pituitary development; however, no
specific Wnt ligand has been implicated in the regulation of
these transcription factors.
The canonical Wnt pathway converts members of the TCF/
LEF family of transcription factors from repressors to activators
of downstream target genes. Awide range of single and double
knockout models of the TCF/LEF family members have been
used to decipher the important roles they play in mouse
development (Galceran et al., 1999; Gregorieff et al., 2004;
Korinek et al., 1998; Merrill et al., 2004; van Genderen et al.,
1994; Verbeek et al., 1995). Several TCF/LEF family members
are expressed during pituitary gland development (Olson et al.,
2006), and the absence of Tcf4 (officially known as Tcf7l2) leads
to pituitary gland hyperplasia, suggesting that canonical Wnt
signaling could regulate pituitary gland growth through TCF4
(Brinkmeier et al., 2003).
The ventral diencephalon and Rathke’s pouch develop from
neighboring areas of the embryo that remains in intimate contact
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active or passive process, but signaling between these structures
is required for proper pituitary gland development (Gleiberman
et al., 1999; Treier et al., 1998). The ventral diencephalon
provides the inductive factors necessary for the invagination of
the oral ectoderm and the subsequent proliferation of the early
progenitor cells to form Rathke’s pouch. BMP4 is a key
signaling factor in the induction of the oral ectoderm. The
invagination of Rathke’s pouch is absent in Bmp4−/− mice
(Takuma et al., 1998), and excess BMP signaling in Noggin
(BMP inhibitor) deficient mice results in multiple invaginations
of Rathke’s pouch (Davis and Camper, 2007). In addition, FGF
signaling from the ventral diencephalon is necessary for both
expression of Lhx3 and cell survival in Rathke’s pouch (De
Moerlooze et al., 2000; Kimura et al., 1996; Norlin et al., 2000;
Ohuchi et al., 2000; Takuma et al., 1998). Rathke’s pouch
invaginates properly in the absence of Fgf8, Fgf10 or Fgfr2
(IIIB), but Lhx3 is not activated, and cells in Rathke’s pouch
undergo excessive apoptosis (De Moerlooze et al., 2000;
Ohuchi et al., 2000; Takuma et al., 1998). Lhx3 and Lhx4
deficiencies cause extensive cell death within the pouch
(Raetzman et al., 2002; unpublished observations). Thus, FGF
and BMP signaling from the ventral diencephalon, as well as
Lhx transcriptional regulation, are required for normal pituitary
gland development (Treier et al., 1998).
Wnt signaling negatively regulates growth by antagonizing
FGF and BMP signaling in multiple organs including the lung,
teeth, and brain (Bellusci et al., 1996, 1997; Clark et al., 2001;
Dean et al., 2005; Kratochwil et al., 2002; Kuschel et al., 2003;
Sasaki et al., 2005; Shimogori et al., 2004; Weaver et al., 1999).
For example, disruption of canonical Wnt signaling in the lung
reduces BMP4 and FGF signaling, resulting in repression of
distal airway epithelial differentiation and expansion of
proximal airway development (Shu et al., 2005). In addition,
overexpression of Wnt5a in the lung results in an increase in
Fgf10 and Bmp4 expression and reduced epithelial branching
(Li et al., 2005).
Despite the strong evidence of interactions between these
pathways in multiple organs, the impact of Wnt signaling on
BMP and FGF pathways has not been assessed in pituitary
organogenesis. We report the temporal and spatial expression
patterns of Tcf4, Tcf3, and Lef1 in the developing pituitary
gland and ventral diencephalon. The results support the
possibility of an interaction between TCF-mediated regulation
of gene expression and BMP and FGF signaling. Consistent
with this idea, we show that loss of Tcf4 permits expansion of
FGF and BMP expression in the ventral diencephalon, with a
concomitant increase in the number of progenitor cells that
form Rathke’s pouch. Six6 transcripts and an extended region
of proliferation can be detected throughout the expanded
population of progenitor cells, suggesting that Six6 may
contribute to pituitary hyperplasia in Tcf4 mutant mice. The
increased pouch size contributes to a 2- to 3-fold increase in the
anterior pituitary volume of TCF4 deficient mice at birth
(Brinkmeier et al., 2003). Thus, TCF4 may play a role as a
repressor to regulate growth of Rathke’s pouch by influencing
BMP and FGF signaling.Materials and methods
Generation of mice
Dr. Hans Clevers, University Medical Center Utrecht, Heidelberglaan
provided mice heterozygous for targeted disruption of the Tcf4 locus. They
have been maintained at the University of Michigan in compliance with the
guidelines set by theUnit of LaboratoryAnimalMedicine. The postnatal lethality
of Tcf4−/− mice necessitates the maintenance of the strain through heterozygous
matings. Genomic DNA, extracted from tail biopsies, was used to genotype mice
at 2 weeks of age. PCR amplification of genomic DNAwith primers specific for
Tcf4 identified the wild type allele and primers recognizing hygromycin
identified the knockout allele (Brinkmeier et al., 2003).
Preparation of tissues
Timed pregnancies were set up with Tcf4+/− matings. The morning the
copulation plug was observed is noted as embryonic day 0.5 (e0.5). For
experiments analyzing the incorporation of 5-Bromo-2′ deoxyuridine (BrdU),
pregnant females were injected intraperitoneally with 100 mg/g body weight of
BrdU 2 h before embryo retrieval. Embryos were dissected at various time points
during development and tail biopsies were used for genotyping as described
above. Embryos were fixed in buffered 4% paraformaldehyde for 30 min to
overnight. After fixation, the embryos were washed in phosphate buffered saline
(PBS) and dehydrated. The embryos were embedded in paraffin, sectioned to
6 μm thickness, and then either stained with hematoxylin & eosin or processed as
described below.
Immunohistochemistry
Sagittal sections of paraffin embedded embryos were used in all of the
immunohistochemistry experiments. Prior to antibody application, slides were
boiled for 10 min in 10 mM citric acid and treated with a 1:1 mixture of
methanol:3% hydrogen peroxide. Mouse anti-TCF4 (1:50; Upstate Cell
Signaling, Temecula, CA), rabbit anti-phospho-SMAD1 (1:200; Cell Signaling
Technologies, Inc., Danvers, MA), mouse anti-p27 (1:150; Oncogene Research
Products, Boston, MA), rabbit anti-phospho ERK (1:100; Cell Signaling
Technologies, Inc. Danvers, MA), rabbit anti-human C FOXL2 (1:200, Dr.
Reiner A. Veitia, University of Paris (Cocquet et al., 2002)), rabbit anti-PITX1
(1:200; Jacques Drouin, Laboratory of Molecular Genetics, University of
Montreal), rabbit anti-PITX2 (1:200; Tord Hjalt, Department for Cell and
Molecular Biology, Lund University, Sweden), mouse anti-NOTCH2 (1:150;
Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA),
and mouse anti-activated β-catenin (1:100; Upstate Cell Signaling, Temecula,
CA) were incubated overnight at 4 °C. The following day the sections were
washed and then incubated with either a biotinylated anti-mouse IgG (1:200;
Vectastain Mouse on Mouse Kit, Vector Laboratories, Burlingame, CA) or a
biotinylated anti-rabbit IgG (1:200, Jackson ImmunoResearch Laboratories, Inc.
West Grove, PA). The antibodies were detected using the reagents and protocols
provided in the tyramide signal amplification (TSA) fluorescein kit (Perkin
Elmer, Boston, MA). Rabbit anti-CyclinD2 (1:200; Santa Cruz Biotechnology,
Santa Cruz, CA) and mouse anti-LHX3 (1:1000; Developmental Studies
HybridomaBank, University of Iowa, Iowa City, IA) were incubated overnight at
4 °C. The following day, the sections were washed and incubated with the species
appropriate biotin conjugated IgG as described above. This was followed by
incubation with a streptavidin-conjugated Cy2 fluorophore (1:200; Jackson
ImmunoResearch Laboratories). Mouse anti-ISL1 (1:600; Developmental
Studies Hybridoma Bank, University of Iowa, Iowa City, IA) was also incubated
overnight at 4 °C. Biotinylated secondary antibodies were used in conjunction
with the TSA Fluorescein kit as described above or with avidin and biotinylated
peroxidase (Vectastain Mouse On Mouse kit, Vector Laboratories). With this
experiment, either diaminobenzidine (DAB) was used as the chromogen (Sigma,
St. Louis,MO) or the tissues were processedwith the TSA-fluorescein kit (Perkin
Elmer, Boston, MA). For the cell proliferation studies, a rat anti-BrdU (1:100;
Harlan Sera, Belton, UK) was incubated overnight at 4 °C. After a series of
washes, the sections were then incubated with a biotin-conjugated rat IgG (1:200;
Jackson ImmunoResearch) followed by the streptavidin-conjugated Cy2
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terminal deoxyuridine triphosphate nick end labeling method (TUNEL) as
previously described (Ward et al., 2006) using the In situ cell death detection kit
(Roche, Indianapolis, IN).
In situ hybridization
In situ hybridization was performed on 6 μm sections using riboprobes
labeledwith digoxigenin (Roche, Indianapolis, IN) (Douglas et al., 2001). A Lef1
cDNA clone containing the 3′ end of the coding sequence and the 3′UTR (1797–
2455 bp) was a gift from Dr. Hans Clevers. Tcf4E cDNAwas excised with XbaI
from an expression plasmid received from Dr. Greg Dressler (University of
Michigan) and was subcloned into pBluescript KS+. It was linearized with BglI
at 1738 bp in order to specifically label the 3′UTR. A 1.4 kb HindIII (1840 bp to
3040 bp) fragment from the 3′UTR of Tcf4B (a gift from Dr. Greg Dressler) was
subcloned into pBluescript KS+. A Tcf4ΔDBD 900 bp cDNA clone, described in
Douglas et al. (2001) was subcloned into the BamHI and XbaI sites of
pBluescript KS+. A 1600 bp Six6 clone was obtained from an embryonic
pituitary cDNA library RIKEN K720034H14 (Carninci et al., 2003). A 584 bp
Fgf10 cDNA and a 1550 bp Bmp4 cDNA clone were gifts from Dr. Brigid
Hogan, Duke University Medical Center. An 846 bp Prop1 cDNA clone was
used for in situ hybridization as previously described (Cha et al., 2004).Results
Tcf4 is expressed in the ventral diencephalon and Rathke’s
pouch
There are four members of the TCF/LEF family of
transcription factors that share a highly conserved β-catenin
binding domain and an HMG box type DNA binding domain
(Figs. 1A–F). The expression patterns of TCF/LEF familyFig. 1. TCF4 isoforms and conservation within the TCF/LEF family. Amino acid
comparison of TCF/LEF family members in the mouse reveals a high degree of
homology within the β-catenin binding domain and HMG box (patterned boxes
in panels A–F). Percentages depicted in the conserved domains were determined
by comparing the coding sequence to TCF4E (A–C). Alternative splicing results
in three Tcf4 mRNAs and protein isoforms. TCF4, officially named TCF7L2,
can be spliced (∗) downstream of the HMG box to generate the TCF4B and
TCF4E proteins, panels A and B. Panel C shows an alternative splice site (∗)
before the HMG box generates a protein that is missing the DNA binding
domain, TCF4ΔDBD. The unique amino acid domains in the carboxy termini of
TCF4B, TCF4E, and TCF4ΔDBD isoforms are depicted with different patterns.members were analyzed, expanding upon previously published
data by examining the early stages of pituitary organogenesis
(Olson et al., 2006). Lef1 transcripts are not detected in the
ventral diencephalon but are clearly present within the
developing anterior pituitary gland at late stages, initiating at
e14.5 and still detectable at e16.5 (Figs. 2A–D). Tcf3 transcripts
are present throughout the ventral diencephalon and Rathke’s
pouch at e10.5 (Fig. 2F). Tcf3 transcripts are more prevalent in
the rostral domain of the ventral diencephalon than in the caudal
domain from e11.5 through e14.5 and are also detectable in the
dorsal aspect of Rathke’s pouch during this period (Figs. 2G–I).
Tcf1 transcripts are not detectable in the ventral diencephalon or
Rathke’s pouch from e10.5 through e16.5 (data not shown).
Alternate splicing generates three protein isoforms of TCF4.
TCF4B and TCF4E contain both conserved domains but differ
in their carboxy termini (Figs. 1A, B). TCF4ΔDBD lacks the
DNA binding domain but retains the β-catenin binding domain,
suggesting that it could act as an inhibitor of the other isoforms
(Fig. 1C) (Douglas et al., 2001; Kennell et al., 2003). We report
the temporal and spatial expression patterns of TCF4 using
immunohistochemistry with an antibody reactive to all TCF4
isoforms and in situ hybridization with probes designed for the
either the TCF4E isoform specifically or all isoforms combined.
In situ hybridization using a probe that detects all Tcf4 isoforms
reveals expression throughout the caudal and rostral domains of
the ventral diencephalon at e10.5, through e12.5, in addition to
high levels within Rathke’s pouch (Figs. 2K–M). By e13.5
expression becomes localized to the rostral domain of the ventral
diencephalon and the dorsal aspect of Rathke’s pouch (Fig. 2N).
At e14.5 and e16.5, expression is not detected in the developing
pituitary gland, and it is diminished in the rostral domain of the
ventral diencephalon (data not shown). These in situ results
conflict with the previously described protein expression of
TCF4 in the ventral aspect of Rathke’s pouch at e14.5 (Cha et al.,
2004). We analyzed protein expression with an alternate anti-
body and found an overlapping expression pattern with Tcf4
mRNA in the pituitary and in other areas of the embryo,
suggesting that the previous results were not specific. Using the
new antibody, TCF4 immunoreactivity is present within the
ventral diencephalon, Rathke’s pouch, and the adult pituitary
gland (Figs. 2P–S), which corresponds to the location of the
multi-isoform Tcf4 transcripts. Tcf4E specific transcripts are
detectable throughout the caudal and rostral domains of the
ventral diencephalon at e10.5 (Fig. 2U). The caudal (and more
dorsal) domain of the ventral diencephalon is defined by a region
expressing BMP4 and FGF10 (Supplementary Fig. 1), while a
region of sonic hedgehog expression defines the rostral domain
(Ericson et al., 1998; Treier et al., 1998). Tcf4E expression
becomes localized to the lower domain of the ventral
diencephalon beginning at e11.5 and continuing through e12.5
(Figs. 2V, W). The expression of Tcf4E remains high in the
rostral domain of the ventral diencephalon at e13.5 (Fig. 2X) but
begins to diminish by e16.5 (data not shown). In situ hybridi-
zation using a probe that detects both Tcf4B and Tcf4E isoforms
mirrors the expression pattern of the specific Tcf4E isoform
probe (data not shown). The expression domain detected with
the multi-isoform Tcf4 probe, but not the Tcf4E and Tcf4B
Fig. 2. The temporal and spatial expression pattern of Lef1, Tcf3, and Tcf4 in the developing pituitary gland. In situ hybridization was used to analyze Lef1, Tcf3, Tcf4,
and Tcf4E expression in the developing anterior pituitary gland and the adjacent dorsal, caudal domain (cd), and ventral, rostral domain (rd) of the ventral
diencephalon. Immunohistochemistry utilizing an antibody that recognizes all TCF4 isoforms was used to confirm developmental expression. The scale bar in panel U
represents 50 μm and should be applied to e10.5 (A, F, K, P, and U) and e11.5 (B, G, L, O, Q, T, V, and Y) pituitary sections. The scale bar for the e12.5 (B, H, J, M, R,
and V), e13.5 (N and X), and e14.5 (C and I) pituitary sections represents 100 μm and is shown in panel W. The arrow in e12.5 sections labeled with Tcf4Emarks the
boundary between the caudal and rostral domains of the ventral diencephalon. The insets in panels L and V represent sense probes from Tcf4 and Tcf4E, respectively.
Panel S is a high magnification (400×) image of an adult pituitary gland.
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Rathke’s pouch in addition to the ventral diencephalon.
We determined the spatial and temporal pattern of activated
β-catenin using immunohistochemistry (Fig. 3). The strongest
immunoreactivity is notable in the ventral diencephalon from
e10.5 through e14.5 (Figs. 3A–E). The level of staining is lower
in the caudal domain of the ventral diencephalon and the
infundibulum than in the more ventral and rostral area. The
most prominent expression in Rathke’s pouch and its
derivatives is in the rostral tip at e14.5 (Fig. 3E). Selected
cells in the adult anterior lobe contain strongly immunoreactiveβ-catenin (Fig. 3F), which contrasts with embryonic pituitary
stages.
The expression pattern of activated β-catenin, Tcf4, and Tcf3
isoforms suggests that they could influence the development of
Rathke’s pouch indirectly by regulating signals emanating from
the ventral diencephalon, while the expression of Lef1 within
Rathke’s pouch suggests that it could have an intrinsic effect on
pituitary cell maintenance or differentiation. Overexpression of
Tcf4ΔDBD and an engineered dominant negative Tcf4E isoform
missing the β-catenin binding domain, Tcf4Δβ-cat, in Rathke’s
pouch of transgenic mice has no obvious effect on pituitary
Fig. 3. Activated, nuclear localized β-catenin predominates in the ventral diencephalon of developing mice. Immunohistochemistry reveals little or no staining in the
developing pituitary gland from e10.5 through e13.5, with some staining of the rostral tip area at e14.5 (A–E, 200×). Activated β-catenin can be easily detected in the
adult pituitary gland (F, 400×). Activated β-catenin can also be detected in other known regions of WNT signaling such as e12.5 brain (G, 50×) and e16.5 intestine
(H, 100×). Sections incubated without primary antibody do not show any nuclear staining (I, e13.5 brain, 50×).
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transgenic mouse analysis supports the hypothesis that the
expression TCF4ΔDBD within Rathke’s pouch has little effect
on pituitary development.
Mice with a disruption of Tcf4 that interrupts the HMG box
DNA binding domain were previously described, but the
expression of TCF4 isoforms in these mice has not been
addressed (Brinkmeier et al., 2003; Korinek et al., 1998). In situ
hybridization reveals that, despite low levels of Tcf4 mRNA
expression in the brain (data not shown), Tcf4E transcripts are
not detectable in the ventral diencephalon at e11.5 in Tcf4−/−
mice (Fig. 2Y). mRNAwas detected with the multi-isoform Tcf4
mRNA probe in the ventral diencephalon and Rathke’s pouch of
Tcf4−/− mice at e11.5 (Fig. 2O); however, no TCF4 protein was
detected by immunohistochemistry, implying that the targeted
disruption affects all TCF4 isoforms and is a null allele (Fig. 2T).
Other members of the TCF/LEF family do not appear to
compensate for the loss of TCF4 as the expression of Tcf3 and
Lef1 is unchanged in Tcf4−/− mice (Figs. 2E, J).
Dysmorphology of Rathke’s pouch is evident in Tcf4−/−
mice by 10.5
The absence of TCF4 results in an increase in size of the
developing anterior pituitary gland at e14.5, leading to a 2- to 3-
fold larger volume by e18.5 (Brinkmeier et al., 2003). This
suggests that TCF4 is necessary for regulation of pituitarygrowth. In order to discover the onset of the pituitary growth
abnormality, hematoxylin and eosin stained pituitary sections
from Tcf4−/− mice were compared to similar sections from
Tcf4+/+ littermates at e9.5 through e18.5 (Fig. 4). There are no
obvious morphological changes in Tcf4−/− pituitary glands at
e9.5 relative to wild type (data not shown). By e10.5, the
invaginating Rathke’s pouch in mutants appears to extend
farther rostrally on the side adjacent to the ventral diencephalon
(Figs. 4A, B). This expanded region is more evident at e11.5 as
wild type cells that are separating from the oral ectoderm thin out
and pinch together (Figs. 4C, D). This characteristic thinning of
cells occurs in Tcf4−/− mice at the appropriate location on the
caudal side of the pouch but the thinning on the rostral side
adjacent to the ventral diencephalon is displaced farther rostrally
in the mutants. The characteristic pinching off of Rathke’s pouch
is usually delayed in Tcf4 mutants, but in rare cases it occurs at
e11.5 (n=1 out of 6) (Figs. 4E, F). The size of the mutant pouch
appears larger suggesting that excess oral ectoderm is incorpo-
rated into the developing pituitary gland. Excess cells in the
mutant are even more obvious at e12.5 and e14.5 (Figs. 4G–J).
The size of the mutant anterior pituitary gland is consistently
larger than wild type, and it protrudes through the cartilage plate
at e16.5 and e18.5 (Figs. 4K–N). This suggests that TCF4
normally influences the location at which Rathke’s pouch
separates from the oral ectoderm, which affects the overall size
of the pituitary gland. In the absence of TCF4, additional oral
ectoderm appears to be recruited to form Rathke’s pouch.
401M.L. Brinkmeier et al. / Developmental Biology 311 (2007) 396–407A reduction in cell death and an extended region of
proliferation in Tcf4−/− mice contribute to an increase in the
anterior pituitary gland size
Apoptosis normally occurs at the sites where Rathke’s pouch
separates from the oral ectoderm (Charles et al., 2005). TUNELstaining of Tcf4+/+ mice at e11.5 confirmed the presence of
apoptotic cells in normal mice at the rostral and caudal aspects
of Rathke’s pouch where separation from the oral ectoderm
occurs (Figs. 5A, B). In Tcf4−/− mice the apoptotic cells on the
caudal side of Rathke’s pouch are present at the same time as in
wild type mice; however, apoptotic cells on the rostral side are
rarely detected (Fig. 5G). This rostral region is thicker than
normal, and evidence of apoptosis cannot always be detected in
Tcf4−/− mice (none, n=3; some, n=3, Figs. 5G, H). Apoptotic
cells, when detectable, are localized more rostrally in mutants
than in normal littermates. The homeobox transcription factor
PITX2 is expressed in a rostrally expanded manner in Tcf4−/−
mice (Figs. 5C, I). The separation of Rathke’s pouch from the
oral ectoderm is consistently complete by e12.5 in wild type and
mutant mice (Figs. 5D, J). No PITX2 staining is detected in the
oral ectoderm at e12.5, indicating that the enlarged area of
PITX2 staining at e11.5 is incorporated into the pouch by e12.5.
Cell proliferation was analyzed by the incorporation of BrdU
in normal and Tcf4−/− pituitary glands. The most striking pro-
liferation difference is evident between e10.5 and e11.5 (Figs.
5E, F, K, L). In Tcf4+/+ mice, BrdU staining is more prominent
in Rathke’s pouch than in the oral ectoderm rostral and caudal to
it. Tcf4−/− mice exhibit a larger region of prominent BrdU
staining that extends much farther rostrally at e10.5 (n=2) and
at e11.5 (n=4). The extended area of cell proliferation is evident
within Rathke’s pouch even after it completely separates from
the oral ectoderm in Tcf4−/− embryos at e12.5 (n=3) (Figs. 5N
vs. S). Parasagittal sections from the same embryos were co-
immunostained with BrdU and another homeobox transcription
factor PITX1 to clearly identify Rathke’s pouch material (Suh
et al., 2002). Additional pouch tissue is evident at a midsagittal
level and more parasagittally on both sides of the midline,
suggesting that extra proliferating cells are present throughout
Rathke’s pouch at e12.5 (Figs. 5M, R). The increase in
proliferation is not evident in Tcf4−/− pituitary glands, at e14.5
(Figs. 5O, T). Immunohistochemistry using antibodies against
CyclinD2, a marker of the G1 phase of the cell cycle, confirms
an additional domain of proliferating cells at e12.5 in Tcf4−/−
pituitary glands that is not present in normal mice (n=3) (Figs.
5P, U bracket). Cessation of proliferation in the anterior
pituitary gland appears normal at e12.5, as assessed by
expression of the post-mitotic cell marker p27 in the ventral
aspect of the gland (n=3) (Figs. 5Q, V) (Nakayama et al.,
1996).Fig. 4. Pituitary dysmorphology is evident by e10.5 in Tcf4−/− mice.
Hematoxylin and eosin staining were used to determine the onset of pituitary
dysmorphology in Tcf4−/−mice compared to Tcf4+/+ controls. Rathke's pouch is
thickened and expanded rostrally beginning at e10.5 (A, B, arrow). Thinning of
the oral ectoderm and the separation of Rathke's pouch (C, bracket) are evident
in Tcf4+/+mice at e11.5 (C, E) but are typically delayed in Tcf4−/−mice (D). One
example of the separation of the pouch from the oral ectoderm has been
identified in a Tcf4−/−mouse at e11.5 (F). The thickened and expanded Rathke's
pouch is separated from the oral ectoderm by e12.5 in Tcf4−/− mice, and the
additional cells are incorporated into the anterior pituitary (H, arrowhead).
Sagittal sections from fetuses at e10.5 through e16.5 (A–L) are oriented with
rostral on the left and e18.5 (M, N) are coronal sections. Panels from e10.5
through e14.5 are the same magnification; e16.5 and e18.5 are at a lower
magnification. The scale bars in panels A and K represent 100 μm.
Fig. 5. Rathke's pouch dysmorphology in Tcf4−/− mice is caused by an inappropriate separation from the oral ectoderm and an increased zone of proliferating cells.
TUNEL staining showed apoptotic cells at the rostral and caudal edges where Rathke's pouch separates from the oral ectoderm in e11.5 Tcf4+/+ mice (A, B). TUNEL
staining is absent on the rostral side of Rathke's pouch in the majority of Tcf4−/− mice (G and inset G′). Separation of Rathke's pouch from the oral ectoderm and
TUNEL positive cells can be identified on rare occasions in Tcf4−/−mouse (H, inset H′). The rostral edge of apoptosis is boxed in panels A, B, G, and H and shown in
the higher magnification insets A′, B′, G′, and H′. The cells forming Rathke's pouch are outlined in white in the TUNEL panels A, B, G, H. The expression of PITX2
at e11.5 and e12.5 was used to mark Rathke's pouch cells (C, D, I, J). Proliferation of cells in Rathke's pouch between e10.5 and e14.5 was analyzed in Tcf4+/+ and
Tcf4−/−mice (E, F, K, L–O, R–T). BrdU immunohistochemistry reveals a zone of increased proliferation on the rostral side of Rathke's pouch in Tcf4−/−mice (K, L, R,
S). The arrows in e10.5 denote the rostral ventral boundary of BrdU detection (E, K), which is expanded in Tcf4−/− mice. The arrowhead in e11.5 panels F and L
denotes the expanded boundary between proliferating and nonproliferating cells in Rathke's pouch of Tcf4−/− mice compared to Tcf4+/+ mice. The additional
proliferating cells in Tcf4−/− mice are incorporated into the rostral ventral side of Rathke's pouch by e12.5 in both parasagittal (R) and midsagittal (S) sections.
Proliferating cells are absent in comparable regions of Rathke's pouch in Tcf4+/+ mice (M, N). Parasagittal sections were co-immunostained with PITX1 in red to
clearly identify Rathke's pouch cells (M, R). There were no differences in proliferation at e14.5 between Tcf4+/+ and Tcf4−/−mice (O, T). Rathke's pouch is outlined in
e12.5 and e14.5 midsagittal sections (N, O, S, T). CyclinD2 immunoreactivity, marking the G1 phase of the cell cycle, was used to confirm the additional region of
proliferation at e12.5 (P vs. U, bracket). p27 immunoreactivity, marking post-mitotic cells, is present in the portion of Rathke's pouch that ceases proliferation in both
Tcf4+/+ and Tcf4−/−mice at 12.5 (Q, V). Panels C–E, I, J, K, and M–V were taken at the same magnification, and the scale bar in panel E represents 100 μm. Panels A,
B, F, G, H, and L were taken at the same magnification, and the scale bar in panel F represents 50 μm.
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after the separation from the oral ectoderm around e11.5 in wild
type mice (Mullis, 2001). ISL1, which is initially expressed
throughout Rathke’s pouch, becomes concentrated in the ventral
cells at e11.5 (Fig. 6A) (Treier et al., 1998). In Tcf4−/− mice,
ISL1 is detectable throughout Rathke’s pouch at e11.5 and does
not become localized to the ventral cells until e12.5 (Figs.
6B–D). Another marker of differentiation, FOXL2, is readily
detected in the ventral aspect of Rathke’s pouch cells of normal
mice by e11.5 (Fig. 6E) (Ellsworth et al., 2006). FOXL2 is not
detectable in the pouch cells of Tcf4−/− mice at e11.5, but its
expression recovers completely by e12.5 (Figs. 6F–H). Both
ISL1 and FOXL2 expression suggest a delay in the ventral celldifferentiation program. Six6 is expressed in a reciprocal
pattern to that of ISL1 and FOXL2. Six6 is a transcription
factor that stimulates progenitor cell proliferation in the
pituitary (Li et al., 2002). Six6 transcripts are detected in the
rostral domain of the ventral diencephalon and the dorsal and
middle regions of Rathke’s pouch in normal mice at e11.5 (Fig.
6I, bracket). In Tcf4−/− mice the expression of Six6 is
appropriately concentrated in these regions, but expression on
the side adjacent to the ventral diencephalon is expanded
rostrally and ventrally (n=3) (Fig. 5J, bracket). The extended
area of Six6 expression in Tcf4 mutants corresponds to the
extended area of proliferating cells (Figs. 5L, 6J). The
expression of the early markers LHX3, NOTCH2, and Prop1
Fig. 6. Differentiation of ventral Rathke's pouch cells is delayed in Tcf4−/−mice.
Immunohistochemistry for ISL1 at e11.5 (A, B) and e12.5 (C, D) as well as
FOXL2 at e11.5 (E, F) and e12.5 (G, H) was used to determine the onset of cell
differentiation in the ventral aspect of Rathke's pouch. In situ hybridization for
Six6 at e11.5 (I, J) and immunohistochemistry for LHX3 at e12.5 (K, L) were
used to analyze the progress of cell differentiation in the dorsal aspect of Rathke's
pouch. The brackets in panels I and J mark the region void of Six6 expression.
Fig. 7. The boundaries of BMP and FGF signaling are expanded rostrally in
Tcf4−/− mice. In situ hybridization for Fgf10 at e11.5 (A, B) and Bmp4 at e11.5
(C, D) and immunohistochemistry for the phosphorylated form of SMAD1,
pSMAD1, a protein activated by BMP, at e10.5 (E, F) were examined in Tcf4+/+
and Tcf4−/− mice. The boundaries Fgf10, Bmp4, and pSMAD1 expression in the
ventral diencephalon are expanded rostrally in Tcf4−/− mice (A–F, arrows).
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mice (Figs. 6K, L and data not shown).
TCF4 mutants exhibit increased FGF and BMP signaling
Wnt signaling regulates FGF and BMP signaling in the
organogenesis of many tissues (Jiang and Harrison, 2005;Litsiou et al., 2005; Shu et al., 2005). FGF10 and BMP
positively regulate pituitary gland growth and cell survival
(Ericson et al., 1998; Norlin et al., 2000; Ohuchi et al., 2000).
This contrasts with TCF4, which negatively regulates pituitary
growth (Brinkmeier et al., 2003). Based on these previous
studies and on the expression patterns of FGF, BMP, and TCF4
in the ventral diencephalon and Rathke’s pouch (Supplementary
Fig. 1), we hypothesize that WNTsignaling negatively regulates
FGF and BMP mediated stimulation of pituitary gland growth
and cell survival. To test this idea, we compared expression
patterns of Fgf10, Bmp4, and pSMAD1 in Tcf4+/+ and Tcf4−/−
embryos. Fgf10 transcripts are most prominent in the dorsal and
caudal domain of the ventral diencephalon at e11.5 in Tcf4+/+
mice (Fig. 7A, arrow). The expression domain of Fgf10 is
expanded rostrally in the ventral diencephalon in Tcf4−/− mice
at e11.5 (n=3) (Fig. 7B, arrow). In some tissues, FGF signaling
causes the phosphorylation of ERK. However, pERK does not
appear to mark FGF signaling in the pituitary gland (Supple-
mentary Fig. 4). Bmp4 mRNA is detected in a region of the
ventral diencephalon that is expanded rostrally and ventrally in
Tcf4−/− mice at e11.5 relative to wild type (n=3) (Figs. 7C, D,
arrows). Consistent with this observation, immunohistochem-
istry with antibodies against phospho-SMAD1, a protein
activated by BMP signaling, reveals a rostral and ventral
Fig. 8. The rostral expansion of the FGF and BMP boundary in Tcf4−/− mice
increases the amount of oral ectoderm specified to invaginate and become
Rathke's pouch. As Rathke's pouch invaginates at e11.5, opposing boundaries
of FGF/BMP and TCF4 expression are established within the ventral
diencephalon. This pattern of expression in the ventral diencephalon likely
influences the adjacent cells within Rathke's pouch to proliferate. The ventral
boundary on each side of Rathke's pouch establishes the pinch off point from the
oral ectoderm and determines the subsequent size of the pituitary gland. In
Tcf4−/− mice, the absence of TCF4 signal in the ventral diencephalon results in
ventral expansion of the FGF/BMP expression boundary. This establishes a
larger region of proliferating cells in Rathke's pouch, potentially leading to
recruitment of additional oral ectoderm, and ultimately a larger pituitary gland.
404 M.L. Brinkmeier et al. / Developmental Biology 311 (2007) 396–407expansion of the BMP signaling domain in TCF4 mutants
relative to wild type at e10.5 (n=3) (Figs. 7E, F, arrows). The
expansion of FGF and BMP signaling in the ventral
diencephalon is implicated as a mechanism for recruiting
additional oral ectoderm tissue into Rathke’s pouch and en-
hancing pituitary growth and size.
Discussion
Several lines of investigation have implicated canonical Wnt
signaling as an important process in the pituitary development
(Ai et al., 2007; Brinkmeier et al., 2003; Cha et al., 2004;
Douglas et al., 2001; Kioussi et al., 2002; Olson et al., 2006;
Salisbury et al., 2007; Treier et al., 1998). The foundation for
understanding this process requires an in-depth knowledge of
the temporal and spatial expression patterns of the genes
regulated by canonical WNT signaling during pituitary devel-
opment, such as the TCF/LEF family. From our expression
analysis we predict that TCF3 and TCF4 may have overlapping
roles and act both extrinsically and intrinsically on pituitary
development. Extrinsic effects of TCF3 and TCF4 may involve
regulation of genes expressed in the ventral diencephalon that
induce development of the pituitary primordium, as we illustrate
here for TCF4 and the BMP and FGF signaling pathways. TCF3
and TCF4 may also act intrinsically during pituitary develop-
ment to regulate pituitary precursor cells exiting the cell cycle to
begin differentiation. This idea is supported by our demonstra-
tion that nuclear localized β-catenin predominates in the ventral
diencephalon during the time that Rathke’s pouch formation is
being induced. LEF1 likely has a later, intrinsic role as the
individualized hormone-producing cells within the anterior lobe
complete their differentiation process (Olson et al., 2006).
These ideas for the roles of TCF/LEF family members in
pituitary development are supported by their known roles in
other organs where TCF4 and TCF3 are important in the
advancement of early precursor cell populations (Korinek et al.,
1998; Merrill et al., 2004). TCF4 is crucial in maintaining the
proliferative compartment of the crypts in between the villi of
the small intestine (Korinek et al., 1998), and TCF3 is required
to restrict the induction of the anterior–posterior axis during
early gastrulation (Merrill et al., 2004). In contrast, LEF1 is not
required for early induction or proliferation in the tooth bud, but
it is required for cell survival in the early tooth bud and
advancement from the late bud stage (Sasaki et al., 2005).
TCF4 mutants have normal proportions of differentiated
pituitary cell types at birth, but the anterior lobe of the organ is
dramatically enlarged (Brinkmeier et al., 2003). The effects of
the targeted disruption of Tcf4 on the expression of TCF4
isoforms and the mechanism whereby TCF4 regulates pituitary
growth had not been investigated previously. We report that two
of the TCF4 isoforms (Tcf4B and E) are expressed primarily in
the rostral domain of the ventral diencephalon, while
Tcf4ΔDBD, an isoform that lacks the HMG box DNA binding
domain, is expressed in the dorsal cells of Rathke’s pouch. We
show that the targeted disruption of Tcf4 is essentially a null
allele, with no detectable protein isoforms. Using these mice, we
demonstrate that TCF4 is necessary for normal expression ofother critical pituitary factors in both the ventral diencephalon
and in the dorsal aspect of Rathke’s pouch.
The overgrowth of the anterior lobe of the pituitary gland in
TCF4 deficient mice is associated with an expansion of the area
of oral ectoderm that is recruited to form pituitary precursors.
Previous studies have shown that BMP and FGF signals
emanating from the ventral diencephalon are critical for the
induction of Rathke’s pouch (Davis and Camper, 2007; Takuma
et al., 1998). We show that both of these expression domains are
expanded in TCF4 mutants. It is plausible that excessive
signaling causes the recruitment of excess oral ectoderm tissue to
form the pouch and that canonicalWNTsignaling, via regulation
of TCF4 activity, influences the output of the BMP and FGF
signaling pathways (Fig. 8). This idea is consistent with studies
that reveal antagonism between canonical WNT signaling and
the BMP and FGF pathways in other organs. For example, the
balance of WNT, BMP, and FGF signaling pathways regulates
growth and development of the cerebral cortex and neural crest
induction (Shimogori et al., 2004; reviewed in Basch and
Bronner-Fraser, 2006). WNT and BMP signals emanating from
the cerebral cortex antagonize FGF signals from the anterior
telencephalon. The balance within these signaling centers
establishes the appropriate expression of transcription factors
that initiate differentiation and organ development. The interac-
tion of the WNT, FGF, and BMP signaling pathways influences
neural crest induction, possibly by a gradient of BMP signaling
that establishes a zone of ectoderm competent to respond to
WNT and FGF signals or by modulating effects of WNT and
FGF signaling on BMP signaling activity (reviewed in Litsiou et
al., 2005; Raible and Ragland, 2005). We have shown that
TCF4, a key element in theWNTsignaling pathway, restricts the
domain of FGF and BMP expression in the ventral diencepha-
lon, reducing the induction of pituitary progenitor cells.
405M.L. Brinkmeier et al. / Developmental Biology 311 (2007) 396–407Negative regulation of organ size through Wnt antagonism
of FGF and BMP action has also been seen in the lung (Dean et
al., 2005). In this study, canonical Wnt signaling negatively
regulates branching of the lung bud and is important for
controlling FGF and BMP signals, which positively regulate
this process. We hypothesize that, upon activation of canonical
Wnt signaling in the ventral diencephalon during early
development, TCF4, either directly or indirectly, represses
Bmp4 and Fgf10 within the rostral domain of the ventral
diencephalon to promote the proper growth and shape of
Rathke’s pouch.
The expanded FGF and BMP signaling domain in TCF4
mutants is associated with an extended region of proliferating
cells that compose Rathke’s pouch and that express markers of
pituitary cell commitment such as PITX genes and Six6 (Fig. 6).
Six6 enhances proliferation of pituitary cells by inhibiting
cyclin-dependent kinase inhibitors (Li et al., 2002), and the
expansion of Six6 expression in TCF4 mutants coincides with
the area of additional proliferating cells in Tcf4−/− mice. It is
intriguing that Six6 is expressed normally within the ventral
diencephalon of Tcf4 mutant mice, despite the expanded
expression of Six6 in Rathke’s pouch. This means that Six6
expression is regulated differently in neural and oral ectoderm.
The expression of Six6 in the ventral and rostral aspect of
Rathke’s pouch may be established by WNT signaling
emanating from the neural ectoderm. These results imply that
the role of Tcf4 in pituitary development is to down-regulate
pituitary gland size by restricting or antagonizing FGF and BMP
signaling.
Several other genes are involved in limiting the rostral
expansion of Rathke’s pouch. Rx, a homeobox gene required for
development of the brain and eye, is expressed throughout the
ventral diencephalon early in mouse development (Voronina et
al., 2005; Mathers, personal communication). In Rx mutant
mice, Rathke’s pouch is expanded and exhibits a similar
extension of Six6 expression that coincides with increased cell
proliferation. In addition, Rx−/− and Tcf4−/− mice both have a
rostral extension of the FGF and BMP boundary in the ventral
diencephalon (Mathers, personal communication; Figs. 7A–D).
The maintenance of this boundary is important for inducing an
appropriately shaped and sized Rathke’s pouch. For example
Sox3+/− mice exhibit rostral extension of the FGF and BMP
expression region and altered pituitary gland morphology
(Rizzoti et al., 2004). The pituitaries of Wnt5a−/− mice exhibit
dysmorphology similar to that of Sox3+/− mice (Camper, 2004;
Cha et al., 2004), and the disruption of the BMP and FGF
boundary is also evident in these mutants (unpublished
observations). Finally, lack of the BMP inhibitor, noggin, results
in altered FGF signaling and abnormal pituitary shape (Davis
and Camper, 2007). Taken together, these results support the
idea that balancing the BMP, FGF, andWNTsignaling pathways
in the ventral diencephalon is important for normal induction of
Rathke’s pouch and pituitary growth.
The relevance of integrating WNT, BMP, and FGF signaling
for maintenance of normal pituitary gland for normal pituitary
gland growth may extend to adulthood. TCF4, noggin, and
activated β-catenin are active in a subset of cells in the adultpituitary gland (Figs. 2, 3; Davis et al., 2007). The role of TCF4
or noggin at this stage cannot be addressed with the current
knockout mouse models because of neonatal lethality. However,
floxed alleles would be useful for determining whether WNT
signaling regulates the expansion of specialized pituitary cell
populations in response to hormonal feedback from target
organs (Pakarinen et al., 1994; Torres et al., 1995) and to test
whether dysregulation of TCF/LEF and/orWNTsignaling could
contribute to abnormalities in adult pituitary gland function such
as adenoma formation. Indeed, there is a high incidence of
accumulation of nuclear β-catenin in pituitary adenomas
(Semba et al., 2001). Consistent with this, TCF4 expression is
reduced in a subset of breast cancers, and it is hypothesized to
repress proliferation of normal breast cells by suppressing
expression of the cell cycle gene CD24 (Shulewitz et al., 2006).
The loss of TCF4 may relieve the suppression of the cell cycle
gene CD24, thus driving proliferation. This supports the idea
that excess canonical Wnt signaling or inappropriate TCF func-
tion could contribute to pituitary hyperplasia.
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